Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-26-000439

Chief Executive Officer disposed of 98,534 shares (other)

  • Chief Executive Officer acquired 670,608 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-27 Grant or award : show line 1 in the form −670,608 2,458,758 D
2026-03-27 Other disposition : show line 2 in the form −98,534 $3.07 $302,499 2,360,224 D
Loading xslF345X06/ownership.xml…